---
{"dg-publish":true,"permalink":"/research/tags/osteoarthritis/","updated":"2025-01-30T16:25:43-05:00"}
---

# Tagged Content
<div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Takeaways</span><span class="dataview small-text">3</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Takeaways/2025-01-31 14-37-21.md" data-href="Research/Takeaways/2025-01-31 14-37-21.md" href="Research/Takeaways/2025-01-31 14-37-21.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-31 14-37-21</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>A protein-restricted <a data-href="Ketogenic Diet" href="Ketogenic Diet" class="internal-link" target="_blank" rel="noopener nofollow">Ketogenic Diet</a> may reduce the progression of <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> when blood <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> levels are maintained ~3.0 mM and there is no weight loss.</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Takeaways/2025-01-28 20-20-37.md" data-href="Research/Takeaways/2025-01-28 20-20-37.md" href="Research/Takeaways/2025-01-28 20-20-37.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 20-20-37</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>A <a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> dose of at least 20.3 mg/kg/day may reduce the pain from <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Takeaways/2025-01-28 20-19-26.md" data-href="Research/Takeaways/2025-01-28 20-19-26.md" href="Research/Takeaways/2025-01-28 20-19-26.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 20-19-26</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>A <a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> dose of at least 20.3 mg/kg/day may reduce the progression of <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a></span></td></tr></tbody></table></div><div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Insights</span><span class="dataview small-text">10</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-30-53.md" data-href="Research/Insights/2025-01-30 15-30-53.md" href="Research/Insights/2025-01-30 15-30-53.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-30-53</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> reduces the serum levels of <a data-href="Matrix Metalloproteinase-3 (MMP3)" href="Matrix Metalloproteinase-3 (MMP3)" class="internal-link" target="_blank" rel="noopener nofollow">Matrix Metalloproteinase-3 (MMP3)</a> in mice at a dose of 250 mg/kg/day, but not 50 mg/kg/day, compared to control when taken for 8 weeks after the induction of experimental <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> at 4 months of age</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-26-59.md" data-href="Research/Insights/2025-01-30 15-26-59.md" href="Research/Insights/2025-01-30 15-26-59.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-26-59</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> reduces the knee OARSI score of mice at a dose of 250 mg/kg/day, but not 50 mg/kg/day, compared to control when taken for 8 weeks after the induction of experimental <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> at 4 months of age</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-23-29.md" data-href="Research/Insights/2025-01-30 15-23-29.md" href="Research/Insights/2025-01-30 15-23-29.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-23-29</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> reduces markers of the progression of knee <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> at a dose of 250 mg/kg/day, but not 50 mg/kg/day, compared to control when taken for 8 weeks after the induction of experimental <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> at 4 months of age</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-23-01.md" data-href="Research/Insights/2025-01-30 15-23-01.md" href="Research/Insights/2025-01-30 15-23-01.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-23-01</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> may reduce the pain response to a 4g Von Frey filament at a dose of either 250 mg/kg/day or 50 mg/kg/day compared to control when taken for 8 weeks after the induction of experimental <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> at 4 months of age</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-21-19.md" data-href="Research/Insights/2025-01-30 15-21-19.md" href="Research/Insights/2025-01-30 15-21-19.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-21-19</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> may reduce the pain response to a 4g Von Frey filament at a dose of 250 mg/kg/day, but not 50 mg/kg/day, compared to control when taken for 4 weeks after the induction of experimental <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> at 4 months of age</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-20-59.md" data-href="Research/Insights/2025-01-30 15-20-59.md" href="Research/Insights/2025-01-30 15-20-59.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-20-59</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> may reduce the pain from knee <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> in mice at a dose of either 250 mg/kg/day or 50 mg/kg/day when taken for 8 weeks after the induction of experimental <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> at 4 months of age</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-18-57.md" data-href="Research/Insights/2025-01-30 15-18-57.md" href="Research/Insights/2025-01-30 15-18-57.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-18-57</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> may reduce knee <a data-href="Sinovitis" href="Sinovitis" class="internal-link" target="_blank" rel="noopener nofollow">Sinovitis</a> at a dose of 250 mg/kg/day, but not 50 mg/kg/day, compared to control when taken for 8 weeks after the induction of experimental <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> at 4 months of age</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-18-26.md" data-href="Research/Insights/2025-01-30 15-18-26.md" href="Research/Insights/2025-01-30 15-18-26.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-18-26</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> increases the cell number in non-calcified knee <a data-href="Cartilage" href="Cartilage" class="internal-link" target="_blank" rel="noopener nofollow">Cartilage</a> of mice at a dose of 250 mg/kg/day, but not 50 mg/kg/day, compared to control when taken for 8 weeks after the induction of experimental <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> at 4 months of age</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-11-44.md" data-href="Research/Insights/2025-01-30 15-11-44.md" href="Research/Insights/2025-01-30 15-11-44.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-11-44</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> can reduce the pain response to a 1g Von Frey filament at a dose of 250 mg/kg/day, but not 50 mg/kg/day, compared to control when taken for 8 weeks after the induction of experimental <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> at 4 months of age</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-29 10-43-15.md" data-href="Research/Insights/2025-01-29 10-43-15.md" href="Research/Insights/2025-01-29 10-43-15.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-29 10-43-15</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>A <a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> dose of 250 mg/kg/day is likely better than a dose of 50 mg/kg/day at reducing the pain from knee <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> in mice when taken for 8 weeks after the induction of experimental arthritis at 4 months of age</span></td></tr></tbody></table></div><div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Quick Notes</span><span class="dataview small-text">2</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-01-31 14-23-42.md" data-href="Research/Quick Notes/2025-01-31 14-23-42.md" href="Research/Quick Notes/2025-01-31 14-23-42.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-31 14-23-42</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span> A <a data-href="Ketogenic Diet" href="Ketogenic Diet" class="internal-link" target="_blank" rel="noopener nofollow">Ketogenic Diet</a> can worsen the progression of <a data-href="Knee" href="Knee" class="internal-link" target="_blank" rel="noopener nofollow">Knee</a> <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> in mice who maintain <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> levels ~ 1.28 mM compared to control rats with BHB levels ~0.87 mM when ketogenic-diet-fed mice lose weight post-injury and control mice do not. This is potentially due to ketogenic-diet-induced changes in the <a data-tooltip-position="top" aria-label="Research/Tags/Gut Microbiome" data-href="Research/Tags/Gut Microbiome" href="Research/Tags/Gut Microbiome" class="internal-link" target="_blank" rel="noopener nofollow">Gut Microbiome</a>. Ketogenic diet protein composition 22.4% of calories and control diet protein composition 24% of calories.</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Quick Notes/2025-01-28 19-22-32.md" data-href="Research/Quick Notes/2025-01-28 19-22-32.md" href="Research/Quick Notes/2025-01-28 19-22-32.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 19-22-32</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>A <a data-href="Ketogenic Diet" href="Ketogenic Diet" class="internal-link" target="_blank" rel="noopener nofollow">Ketogenic Diet</a> can reduce the progression of <a data-href="Knee" href="Knee" class="internal-link" target="_blank" rel="noopener nofollow">Knee</a> <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> via inhibition of the <a data-href="NLRP3 Inflammasome" href="NLRP3 Inflammasome" class="internal-link" target="_blank" rel="noopener nofollow">NLRP3 Inflammasome</a> in rats who maintain <a data-href="Beta-Hydroxybutyrate (BHB)" href="Beta-Hydroxybutyrate (BHB)" class="internal-link" target="_blank" rel="noopener nofollow">Beta-Hydroxybutyrate (BHB)</a> levels ~ 3.0 mM compared to control rats with BHB levels ~0.4-0.8 mM independent of weight. Ketogenic diet protein composition ~10.9% kcal and control diet protein composition ~18.3% kcal.</span></td></tr></tbody></table></div><div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Assumptions</span><span class="dataview small-text">7</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-31 15-13-30.md" data-href="Research/Assumptions/2025-01-31 15-13-30.md" href="Research/Assumptions/2025-01-31 15-13-30.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-31 15-13-30</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Protein" href="Protein" class="internal-link" target="_blank" rel="noopener nofollow">Protein</a> intake does not impact the effect of a ketogenic diet on <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> progression</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-28 21-34-31.md" data-href="Research/Assumptions/2025-01-28 21-34-31.md" href="Research/Assumptions/2025-01-28 21-34-31.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 21-34-31</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>The progression of knee <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> in damicoUrolithinImprovesMitochondrial2022 is similar to that of humans</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-28 21-35-03.md" data-href="Research/Assumptions/2025-01-28 21-35-03.md" href="Research/Assumptions/2025-01-28 21-35-03.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 21-35-03</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>The progression of all types of <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> is equally sensitive to treatment by <a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-28 21-29-23.md" data-href="Research/Assumptions/2025-01-28 21-29-23.md" href="Research/Assumptions/2025-01-28 21-29-23.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 21-29-23</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>The pain from all types of <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> is equally sensitive to treatment by <a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-28 21-31-22.md" data-href="Research/Assumptions/2025-01-28 21-31-22.md" href="Research/Assumptions/2025-01-28 21-31-22.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 21-31-22</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>The progression of pain from knee <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> in mice in damicoUrolithinImprovesMitochondrial2022 is similar to that of humans</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-28 21-16-36.md" data-href="Research/Assumptions/2025-01-28 21-16-36.md" href="Research/Assumptions/2025-01-28 21-16-36.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 21-16-36</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>The knee <a data-href="Sinovitis" href="Sinovitis" class="internal-link" target="_blank" rel="noopener nofollow">Sinovitis</a> observed in the model of knee <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> in damicoUrolithinImprovesMitochondrial2022 is relevant to humans</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-28 20-49-14.md" data-href="Research/Assumptions/2025-01-28 20-49-14.md" href="Research/Assumptions/2025-01-28 20-49-14.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 20-49-14</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>A Von Frey test is an appropriate test for assessing pain for knee <a data-href="Osteoarthritis" href="Osteoarthritis" class="internal-link" target="_blank" rel="noopener nofollow">Osteoarthritis</a> in mice</span></td></tr></tbody></table></div>

